JOHN TOLBERT: Open Payments
NPI 1811961345 · CARROLLTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,711 in 106 payments from 19 companies in 2025. Trend: 2023 $2,669 · 2024 $3,979 · 2025 $2,711
Food & beverage: $2,711
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $733 |
| ABBVIE INC. | 14 | $357 |
| UCB, Inc. | 7 | $263 |
| Janssen Biotech, Inc. | 18 | $231 |
| Amgen Inc. | 7 | $133 |
| Novartis Pharmaceuticals Corporation | 7 | $129 |
| Lilly USA, LLC | 6 | $126 |
| Regeneron Healthcare Solutions, Inc. | 3 | $113 |
| LEO Pharma Inc. | 4 | $97 |
| PFIZER INC. | 5 | $91 |
Products named: DUPIXENT, Bimzelx, TREMFYA, SKYRIZI, RINVOQ, Otezla, TALTZ, COSENTYX.
Industry payments across GA — which companies pay providers there.
